Balyasny Asset Management
ANGO icon

Balyasny Asset Management’s AngioDynamics ANGO Stock Holding History

Balyasny Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-172,780
Closed -$1.93M – 3052
2025
Q3 		$1.93M Buy
172,780
+133,609
+341% +$1.29M ﹤0.01% 1814
2025
Q2 		$389K Sell
39,171
-60,247
-61% -$590K ﹤0.01% 2391
2025
Q1 		$934K Sell
99,418
-11,433
-10% -$120K ﹤0.01% 2021
2024
Q4 		$1.02M Buy
110,851
+48,522
+78% +$357K ﹤0.01% 1941
2024
Q3 		$485K Buy
62,329
+42,784
+219% +$309K ﹤0.01% 2271
2024
Q2 		$118K Sell
19,545
-5,542
-22% -$34.2K ﹤0.01% 2393
2024
Q1 		$147K Buy
+25,087
New +$149K ﹤0.01% 2461
2023
Q4 		– Sell
-116,596
Closed -$852K – 2470
2023
Q3 		$852K Buy
116,596
+85,517
+275% +$712K ﹤0.01% 1604
2023
Q2 		$324K Sell
31,079
-116,686
-79% -$1.12M ﹤0.01% 1969
2023
Q1 		$1.53M Sell
147,765
-890,648
-86% -$11.4M ﹤0.01% 1561
2022
Q4 		$14.3M Buy
1,038,413
+829,408
+397% +$11.5M 0.04% 603
2022
Q3 		$4.28M Sell
209,005
-246,025
-54% -$5.4M 0.01% 1080
2022
Q2 		$8.8M Buy
455,030
+194,099
+74% +$3.98M 0.03% 701
2022
Q1 		$5.62M Buy
+260,931
New +$5.92M 0.02% 906
2021
Q4 		– Sell
-146,094
Closed -$3.79M – 2206
2021
Q3 		$3.79M Buy
146,094
+71,395
+96% +$1.91M 0.02% 920
2021
Q2 		$2.03M Buy
+74,699
New +$1.82M 0.01% 1004
2016
Q2 		– Sell
-15,000
Closed -$184K – 1148
2016
Q1 		$184K Buy
+15,000
New +$166K ﹤0.01% 1140

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Balyasny Asset Management's ANGO Position: Q4 2025 in Review

Balyasny Asset Management sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 172,780 shares — an estimated $1.93M sold.

Balyasny Asset Management first reported a position in ANGO in Q1 2016 and held it in 17 quarters. The position peaked at $14.3M in Q4 2022. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • Balyasny Asset Management reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 172,780 AngioDynamics shares in Q4 2025, an estimated $1.93M.
  • Balyasny Asset Management first reported a position in AngioDynamics in Q1 2016 and held it in 17 quarters.
  • Balyasny Asset Management's AngioDynamics position peaked at $14.3M in Q4 2022.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.